injection site reaction to tirzepatide & Zepbound Rash and Injection-Site Reactions: Causes, Treatment, and Prevention A. Local site reaction on
Description
Aviles-Olmos, I., Dickson, J., Kefalopoulou, Z., et al

The 4mg dose alone produces 15.2% weight loss, which means it provides substantial biological support for weight maintenance even if the initial loss occurred at a higher dose

It typically occurs in patients with susceptible substrate, either myocardial scar or a genetic predisposition

This model suggests that antitumor effects may be dependent on concurrent administration and not mediated solely by weight loss

The study ended up revealing that doses of 0.2mg Semaglutide daily provided significant body weight reductions when compared with doses of Liraglutide

When managing patients on tirzepatide, our target is for patients to aim for approximately one pound of weight loss each week
